Study of an injection for weight management in healthy and overweight adults
Part of Hormones & metabolism clinical trials.
This study tests a new injected medicine to see if it is safe and how it works in people who are overweight or obese, as well as in healthy volunteers. It may help with weight loss, but it is an early-phase trial to check safety first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and can be male or female.
- You have a body mass index (BMI) between 20 and 40, with a minimum weight of 50 kg for men or 45 kg for women.
- You are not planning pregnancy or fathering a child, and you agree to use birth control during the study and for 6 months after.
- You have not had significant weight changes (more than 5%) in the last 3 months.
- You have not used weight-loss drugs, GLP-1 medicines, or certain other treatments like steroids or psychiatric drugs in the last 3 months.
- You have not had recent skin infections or wounds, severe allergies, pancreatitis, or major surgery in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injection called MWN109 to see if it helps people with overweight or obesity lose weight. It may offer a new treatment option for those who haven't been able to manage their weight with lifestyle changes alone.
This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.
This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.
This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.